From Wikipedia, the free encyclopedia
The term respiratory failure, in medicine, is used to describe
inadequate gas
exchange by the respiratory system, with the result
that arterial oxygen and/or carbon dioxide levels cannot be
maintained within their normal ranges. A drop in blood oxygenation is known as
hypoxemia; a rise in
arterial carbon
dioxide levels is called hypercapnia. The normal reference values
are: oxygen PaO2 > 60 mmHg, and carbon dioxide PaCO2 < 45 mmHg (values in kPa being PO2
below 8kPA and PCO2 above 6.7 kPa). Classification
into type I or type II relates to the absence or presence of
hypercapnia respectively.
Types
Type 1
Type 1 respiratory failure is defined as hypoxaemia without hypercapnia, and indeed
the PaCO2 may be normal or low. It is
typically caused by a ventilation/perfusion (V/Q) mismatch; the volume of
air flowing in and out of the lungs is not matched with the flow of
blood to the lungs. The basic defect in type 1 respiratory failure
is failure of oxygenation characterized by:
-
-
-
| PaO2 |
low (< 60mmHg) |
| PaCO2 |
normal or low (≤ 49mmHg) |
| PA-aO2 |
increased |
This type of respiratory failure is caused by conditions that
affect oxygenation such as:
Type 2
Type 2 respiratory failure is caused by increased airway
resistance; both oxygen and carbon dioxide are affected. Defined as
the build up of carbon dioxide levels (PaCO2)
that has been generated by the body. The underlying causes
include:
- Reduced breathing effort (in the fatigued patient)
- Increased resistance to breathing (such as in asthma)
- A decrease in the area of the lung available for gas exchange
(such as in emphysema).
The basic defect in type 2 respiratory failure is characterized
by:
-
-
-
| PaO2 |
decreased |
| PaCO2 |
increased |
| PA-aO2 |
normal |
| pH |
decreased |
Causes
- Pulmonary dysfunction
- Cardiac dysfunction
- Other
Treatment
Emergency treatment follows the principles of cardiopulmonary
resuscitation. Treatment of the underlying cause is required.
Endotracheal intubation and mechanical ventilation may be
required. Respiratory stimulants such as doxapram may be used, and if
the respiratory failure resulted from an overdose of sedative drugs such as opioids or benzodiazepines, then the appropriate antidote such as naloxone or flumazenil will be
given.
See also
References
|
Pathology of respiratory system (J, 460-519), respiratory
diseases |
|
Upper RT
(including URTIs,
Common cold) |
|
|
Lower RT/lung
disease
(including LRTIs) |
|
|
|
|
|
|
|
|
Pneumoconiosis ( Asbestosis, Baritosis, Bauxite fibrosis, Berylliosis, Caplan's
syndrome, Chalicosis, Coalworker's
pneumoconiosis, Siderosis, Silicosis, Byssinosis)
Hypersensitivity
pneumonitis ( Bagassosis, Bird fancier's lung, Farmer's
lung)
|
|
|
Other
|
|
|
|
|
Obstructive or
restrictive
|
|
|
|
By pathogen
|
|
|
|
By vector/route
|
|
|
|
By distribution
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
|
Pleural
cavity/
mediastinum |
|
|
|
Other/general |
|
|
| respiratory system navs: anat
nose,larynx/lower+thoracic cavity/physio/dev,
noncongen/congen/tumors, symptoms+signs/eponymous, proc |
|